Hadassah

Peace in Sight: An Israeli, Palestinian, and Hadassah Australia Collaboration

Friday, Jan 13 2017

Peace in Sight participant.

St. John of Jerusalem Eye Hospital, in collaboration with Hadassah Medical Organization, has received a €500,000 grant from the European Union to establish a genetic research unit to serve the Palestinian communities.

St. John, established in 1885, has built a reputation for fine ophthalmic care in the region. The primarily Palestinian population that it serves faces many health challenges, not the least being serious eye disease, much of it driven by the very high incidence of consanguineous marriages.

The main missions of Peace in Sight are to:

·       Train a Palestinian ophthalmologist from St. John at Hadassah in molecular genetics and clinical management

·       Study in depth 100-200 Palestinians with hereditary eye diseases to identify the most common ones

·       Establish a fully functional Genetic Disease Laboratory at St John

·       Collect samples from recruited Palestinians and identify the most common genetic patterns of inherited ocular diseases in the Palestinian population

·       Provide counseling for prevention of disease transmission

·       Explore novel treatment modalities, including gene and cell-based therapies

·       Increase awareness of targeted beneficiaries on an individual basis and

·       Facilitate access or travel permits with the Israeli Civil Administration.

The grant of €500,000 for the three-year Peace in Sight project constitutes approximately 80 percent of the total project cost. Hadassah Australia is seeking to raise $50,000 to assist with the remainder. Toward that goal, Hadassah Australia recently held a luncheon at the RANZCO (Royal Australian and New Zealand College of Ophthalmologists) Conference to raise awareness and funds for Peace in Sight, which brought in over $10,000 for the project. Follow-up letters have also been sent out to ophthalmologists who could not attend to raise additional funds.

Ron Finkel, President of Hadassah Australia, reports: “We will be pursuing this campaign through the first quarter of 2017, culminating with the visit to Sydney in late March by Prof. Koby Pe’er, head of the Department of Ophthalmology at Hadassah.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Jun 12 2019

Multinational Study Reveals Reduction in Kidney Disease Progression with Diabetes Drug

In a large multinational study that revealed the effectiveness of a medicine called dapagliflozin in reducing cardiovascular death from heart failure among high-risk diabetic patients, the first sub-analysis of renal data has also identified a 47 percent drop in decline of kidney function and renal death.

READ MORE ›
alt_text

Wednesday, Jun 5 2019

What Causes PMS? Hadassah Study Offers Answer, with Implications for Future Research

A new explanation for the mood swings, irritability, and depression, known as Premenstrual syndrome (PMS) has been suggested by a Hadassah Medical Organization study.

READ MORE ›
alt_text

Wednesday, Jun 5 2019

Hadassah Confronts the Comeback of Measles

Measles, a disease we have not seen for a long time, has come back. In the past year and a half, Israel has seen over 4,000 cases, says Prof. Allon Moses, director of the Department of Clinical Microbiology and Infectious Diseases at the Hadassah Medical Organization.

READ MORE ›
alt_text

Wednesday, May 29 2019

First Cath Lab Opens in Northern Neighborhoods of Jerusalem at Hadassah Mount Scopus

Hadassah Hospital Mount Scopus inaugurated the first advanced cardiac catheterization unit serving Jerusalem’s northern neighborhoods.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More